A judge on Tuesday granted summary judgment in favor of AstraZeneca in a lawsuit alleging that anti-psychotic drug Seroquel caused a Kansas woman to develop diabetes. The dismissal of the case arose after the judge ruled to exclude expert testimony for the plaintiff. The case was scheduled to go to trial next month.